Overview
Monika Richter focuses her practice on the biotechnology and pharmaceuticals sector. She advises national and international clients on various legal matters related to the development and partnering of pharmaceutical compounds and products, with a particular focus on strategic alliances, license agreements, research collaborations and co-development agreements. Her work likewise includes financing and corporate transactions as well as mergers and acquisitions.
Given her Polish background, Monika is active in the Eastern European market, regularly speaking at industry conferences in Poland and advising Polish clients on several cross-border collaborations in the life sciences sector.
Prior to joining McDermott, Monika has worked for other international law firms in Berlin and Frankfurt.
Results
- Advised Paion, a German biotechnology company, on a licensing transaction with a global pharmaceutical company regarding local rights in its asset Remimazolam*
- Advised Selvita, one of Poland’s largest biotechnology companies, on various international licensing and collaboration agreements, including with Orion Pharma, H3, Felicitex, Merck KGaA, Menarini and on a funding agreement with the Leukemia and Lymphoma Society*
- Advised a big Polish pharmaceutical company on a research collaboration with a German pharmaceutical company*
- Advised uniQure on a commercialization agreement for Glybera, the first gene therapy product approved in the EU, with Chiesi and on an exclusive strategic collaboration with Bristol-Myers Squibb*
- Advised several biotechnology companies on multinational bidder transactions directed to licensing agreements with local partners, most recently a US pharmaceutical company on a multinational licensing transaction regarding local rights for a dermatological assets with partners in China, Japan, India and US*
- Advised several biotechnology companies on research and collaboration agreements and IP transfer agreements with universities/university clinics in Germany and other countries of the world*
*Matter handled prior to joining McDermott
Recognitions
- Handelsblatt/Best Lawyers™ 2022 Germany: Leading Lawyer for Biotechnology Law and Life Sciences Practice
- Leaders League’s 2019 guide, Innovation, Technology & Patents, “Excellent” in the Health, pharma & biotechnology category
- The Legal 500 EMEA 2019
